Fennec Pharmaceuticals (FENC) Earnings Date, Estimates & Call Transcripts → Massive Crisis Looming — Protect Your Savings Now (From Weiss Ratings) (Ad) Free FENC Stock Alerts $6.81 +0.05 (+0.74%) (As of 02:06 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 14) $0.41 Missed By -$0.08 Consensus EPS (May. 14) $0.49 Read Call TranscriptListen to Call Get Fennec Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for FENC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueFENC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FENC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsAre you prepared for a financial lockdown?A new kind of American dystopia is being built before our eyes, and most people have no idea what's happening. That's why I've recorded this urgent message to give you all the details on how to prepare … Including three steps to take right now.Click here to watch my video before it's too late. Fennec Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242($0.05)($0.02)($0.04) Q2 20243($0.15)$0.42$0.07 Q3 20243($0.15)$0.24$0.04 Q4 20243($0.06)$0.42$0.13 FY 202411($0.41)$1.06$0.20 Q1 20253$0.05$0.09$0.07 Q2 20253$0.09$0.55$0.28 Q3 20253$0.12$1.27$0.55 Q4 20253$0.13$2.56$1.01 FY 202512$0.39$4.47 $1.91FENC Earnings Date and InformationFennec Pharmaceuticals last released its quarterly earnings results on May 14th, 2024. The reported $0.41 earnings per share for the quarter, missing analysts' consensus estimates of $0.49 by $0.08. The business earned $25.38 million during the quarter, compared to analysts' expectations of $10.46 million. Fennec Pharmaceuticals has generated $0.03 earnings per share over the last year ($0.03 diluted earnings per share) and currently has a price-to-earnings ratio of 225.7. Earnings for Fennec Pharmaceuticals are expected to grow by 41.67% in the coming year, from $0.36 to $0.51 per share. Fennec Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Fennec Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/14/2024Q1 2024$0.49$0.41($0.08)$0.41$10.46 million$25.38 million 3/21/2024Q4 2023$0.02($0.10)($0.12)($0.10)$9.47 million$9.74 million11/6/2023Q3 2023($0.11)($0.07)+$0.04($0.07)$5.22 million$6.52 million 8/3/2023Q2 2023($0.18)($0.21)($0.03)($0.21)$4.01 million$3.33 million5/11/2023Q1 2023($0.21)($0.23)($0.02)($0.23)$1.88 million$1.68 million3/30/2023Q4 2022($0.24)($0.26)($0.02)($0.26)$1.97 million- Get the Latest News and Ratings for FENC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/11/2022Q3 2022($0.17)($0.31)($0.14)($0.31)--8/12/2022Q2 2022($0.10)($0.19)($0.09)($0.19)--5/12/2022Q1 2022($0.13)($0.14)($0.01)($0.14)-- 2/28/2022Q4 2021$3.52($0.18)($3.70)($0.18)--11/10/2021Q3 2021($0.17)($0.16)+$0.01($0.16)--8/10/2021Q2 2021($0.19)($0.15)+$0.04($0.15)--5/13/2021Q1 2021($0.21)($0.18)+$0.03($0.18)--3/29/2021Q4 2020($0.19)($0.13)+$0.06($0.13)-$0.17 million11/15/2020Q3 2020($0.19)($0.24)($0.05)($0.24)--8/5/2020Q2 2020($0.18)($0.21)($0.03)($0.21)--5/14/2020Q1 2020($0.19)($0.19)-($0.19)--2/14/2020Q4($0.13)($0.18)($0.05)($0.18)--11/12/2019Q3($0.20)($0.09)+$0.11($0.09)--8/9/2019Q2 2019($0.14)($0.24)($0.10)($0.24)-- Fennec Pharmaceuticals Earnings - Frequently Asked Questions When is Fennec Pharmaceuticals's earnings date? Fennec Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on FENC's earnings history. Did Fennec Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Fennec Pharmaceuticals (NASDAQ:FENC) missed the analysts' consensus estimate of $0.49 by $0.08 with a reported earnings per share (EPS) of $0.41. Learn more on analysts' earnings estimate vs. FENC's actual earnings. How can I listen to Fennec Pharmaceuticals's earnings conference call? The conference call for Fennec Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Fennec Pharmaceuticals's conference call transcript? The conference call transcript for Fennec Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded annual revenue of $21.25 million. How much profit does Fennec Pharmaceuticals generate each year? Fennec Pharmaceuticals (NASDAQ:FENC) has a recorded net income of -$16.05 million. FENC has generated $0.03 earnings per share over the last four quarters. What is Fennec Pharmaceuticals's price-to-earnings ratio? Fennec Pharmaceuticals (NASDAQ:FENC) has a trailing price-to-earnings ratio of 225.67 and a forward price-to-earnings ratio of 18.81. What is Fennec Pharmaceuticals's EPS forecast for next year? Fennec Pharmaceuticals's earnings are expected to grow from $0.36 per share to $0.51 per share in the next year, which is a 41.67% increase. More Earnings Resources from MarketBeat Related Companies: CARGO Therapeutics Earnings Date ProKidney Earnings Date REGENXBIO Earnings Date Exscientia Earnings Date iTeos Therapeutics Earnings Date Lexeo Therapeutics Earnings Date Valneva Earnings Date Cabaletta Bio Earnings Date Replimune Group Earnings Date Allogene Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple Stock All-Time Highs: Can AI Outweigh Earnings Jitters?CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry Shifts This page (NASDAQ:FENC) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredThe Scary Fed Idea To Turn Your Dollars Into a Digital Power GrabCash is becoming a relic of the past… Soon, Biden and the Federal Reserve plan to replace the dollar with t...Oasis Gold | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.